首页> JAMA oncology> Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Thomas,Powles

第一单位： Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, England2Department of Medical Oncology, Royal Free NHS Foundation Trust, London, England.

作者： Thomas,Powles ^[1] ; Naveed,Sarwar ^[2] ; Andrew,Stockdale ^[3] ; Shah-Jalal,Sarker ^[4] ; Ekaterini,Boleti ^[5] ; Andrew,Protheroe ^[6] ; Robert,Jones ^[7] ; Simon,Chowdhury ^[8] ; John,Peters ^[4] ; Grenville,Oades ^[7] ; Tim,O'Brien ^[8] ; Mark,Sullivan ^[6] ; Michael,Aitchison ^[5] ; Luis,Beltran ^[4] ; Daniel,Worth ^[4] ; Kate,Smith ^[4] ; Constance,Michel ^[4] ; Giorgia,Trevisan ^[4] ; Elizabeth,Harvey-Jones ^[4] ; Akhila,Wimalasingham ^[4] ; Anju,Sahdev ^[4] ; Charlotte,Ackerman ^[4] ; Simon,Crabb ^[9]

作者单位： Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, England2Department of Medical Oncology, Royal Free NHS Foundation Trust, London, England. ^[1] Department of Oncology, Imperial College, London, England. ^[2] Arden Cancer Centre, University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, England. ^[3] Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, England. ^[4] Department of Medical Oncology, Royal Free NHS Foundation Trust, London, England. ^[5] Department of Medical Oncology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, England. ^[6] Beatson West of Scotland Cancer Centre, Glasgow, Scotland. ^[7] Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, England. ^[8] Cancer Sciences Unit, University of Southampton, Southampton, England. ^[9]

医学主题词老年人(Aged);血管生成抑制剂(Angiogenesis Inhibitors);癌, 肾细胞(Carcinoma, Renal Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);吲唑类(Indazoles);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾肿瘤(Kidney Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肾切除术(Nephrectomy);比例危险度模型(Proportional Hazards Models);嘧啶类(Pyrimidines);磺胺类(Sulfonamides);治疗结果(Treatment Outcome)

DOI 10.1001/jamaoncol.2016.1197

PMID 27254750

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

JAMA oncology

2016年2卷10期

1303-1309页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览7

点击下载本期目录封面

JAMA oncology

2016年2卷10期

1303-1309页

检索历史清除

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

JAMA oncology

相似文献

同项目论文

JAMA oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.

JAMA oncology

相似文献

同项目论文

JAMA oncology

相关期刊

检索历史清除